Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population

AIMS: This analysis qualitatively describes the impact of hyperkalaemia (HK) and renin‐angiotensin‐aldosterone system inhibitor (RAASi) use on clinical outcomes in patients with heart failure (HF). METHODS AND RESULTS: Patients were included if they were ≥18 years old; had a serum potassium result b...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhlestein, Joseph B., Kammerer, Jennifer, Bair, Tami L., Knowlton, Kirk U., Le, Viet T., Anderson, Jeffrey L., Lappé, Donald L., May, Heidi T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835576/
https://www.ncbi.nlm.nih.gov/pubmed/33331114
http://dx.doi.org/10.1002/ehf2.13164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835576/
https://www.ncbi.nlm.nih.gov/pubmed/33331114
http://dx.doi.org/10.1002/ehf2.13164

Ejemplares similares